Hainan Haiyao Company Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hainan Haiyao Company Limited with three other
companies in this sector in China:
Zhejiang Jingxin Pharmaceutical Co., Ltd.
sales of 1.41 billion Chinese Renmimbi [US$209.92 million]
of which 99%
was Medicines on sale),
Hunan ER-KANG Pharmaceutical Co Ltd
(1.76 billion Chinese Renmimbi [US$260.59 million]
of which 100%
was Manufacture of Medicines), and
Zhejiang Jiuzhou Pharmaceutical Co Ltd
(1.44 billion Chinese Renmimbi [US$214.35 million]
of which 92%
was Production and sale of chemical active p).
During the year ended December of 2015, sales at
Hainan Haiyao Company Limited were 1.67 billion Chinese Renmimbi (US$248.57 million).
increase of 21.2%
versus 2014, when the company's sales were 1.38 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Hainan Haiyao Company Limited
(and since 2010, sales have increased a total of 173%).
Sales of Bpc saw an increase
that was more than double the company's growth rate: sales were up
47.4% in 2015, from
666.52 million Chinese Renmimbi to 982.18 million Chinese Renmimbi.
Not all segments of Hainan Haiyao Company Limited experienced an increase in sales in 2015:
sales of Preparations fell 5.9% to 866.68 million Chinese Renmimbi.